Financhill
Back

IDEXX Laboratories, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
71

IDXX
IDEXX Laboratories, Inc.

Last Price:
$713.40
Seasonality Move:
4.63%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.24
Seasonality Move:
-11.9%
Buy
71
IDEXX Laboratories, Inc. (IDXX) is a Buy

Is IDEXX Laboratories, Inc. a Buy, Sell or Hold?

  • The current IDEXX Laboratories, Inc. [IDXX] share price is $712.39. The Score for IDXX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • IDXX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IDXX Stock Price Chart

What is IDEXX Laboratories, Inc.'s stock price today?

  • The IDEXX Laboratories, Inc. share price today is $712.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IDXX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

IDXX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 57.5 Buy
Chaikin Money Flow: 453854 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (684.83 - 711.75) Buy
Bollinger Bands (100): (631.49 - 707.57) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

IDXX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 691.59 Buy
20-day SMA: 694.71 Buy
50-day SMA: 700.66 Buy
200-day SMA: 588.3 Buy
8-day EMA: 698.22 Buy
20-day EMA: 697.05 Buy
50-day EMA: 690.56 Buy
200-day EMA: 611.75 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

IDEXX Laboratories, Inc. Earnings Growth & IDXX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.65 per share, and an increase next year of $1.97 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

IDEXX Laboratories, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):